Your browser doesn't support javascript.
loading
Response by Henriksen et al Regarding Article, "Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial".
Henriksen, Peter A; Hall, Peter; Lang, Ninian N.
Affiliation
  • Henriksen PA; British Heart Foundation Centre for Cardiovascular Science (P.A.H.), University of Edinburgh, UK.
  • Hall P; Cancer Research UK - Edinburgh Centre (P.H.), University of Edinburgh, UK.
  • Lang NN; Medical Research Council Institute Genetics and Molecular Medicine (P.H.), University of Edinburgh, UK.
Circulation ; 149(22): e1221-e1222, 2024 May 28.
Article in En | MEDLINE | ID: mdl-38805577
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adrenergic beta-Antagonists / Anthracyclines / Troponin I / Cardiotoxicity Limits: Humans Language: En Journal: Circulation Year: 2024 Document type: Article Affiliation country: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adrenergic beta-Antagonists / Anthracyclines / Troponin I / Cardiotoxicity Limits: Humans Language: En Journal: Circulation Year: 2024 Document type: Article Affiliation country: Reino Unido